Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
Stericycle Inc (SRCL)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/23/2024: SRCL (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -7.99% | Avg. Invested days 45 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 2.0 | Stock Returns Performance 1.0 |
Profits based on simulation | Last Close 12/23/2024 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.75B USD | Price to earnings Ratio 158.92 | 1Y Target Price 61.43 |
Price to earnings Ratio 158.92 | 1Y Target Price 61.43 | ||
Volume (30-day avg) 307482 | Beta 1.11 | 52 Weeks Range 43.99 - 81.10 | Updated Date 12/23/2024 |
52 Weeks Range 43.99 - 81.10 | Updated Date 12/23/2024 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.39 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.77% | Operating Margin (TTM) 6.76% |
Management Effectiveness
Return on Assets (TTM) 2.3% | Return on Equity (TTM) 0.8% |
Valuation
Trailing PE 158.92 | Forward PE 22.37 | Enterprise Value 7664664903 | Price to Sales(TTM) 2.19 |
Enterprise Value 7664664903 | Price to Sales(TTM) 2.19 | ||
Enterprise Value to Revenue 2.91 | Enterprise Value to EBITDA 22.21 | Shares Outstanding 92836400 | Shares Floating 92277636 |
Shares Outstanding 92836400 | Shares Floating 92277636 | ||
Percent Insiders 0.37 | Percent Institutions 88.8 |
AI Summary
Stericycle Inc.: A Comprehensive Overview
Company Profile:
Detailed History and Background:
Stericycle Inc. (NASDAQ: SRCL) was founded in 1989 as a small medical waste disposal company in Illinois. Through acquisitions and organic growth, it has become a leading provider of environmental and regulated waste management solutions with operations in North America, Europe, and Asia-Pacific.
Core Business Areas:
Stericycle's core business areas are:
- Regulated Waste Management: This includes the collection, transportation, treatment, and disposal of medical waste, hazardous waste, and other regulated materials.
- Environmental Solutions: This includes services such as waste recycling, secure document destruction, and retail compliance solutions.
- Compliance Services: This includes regulatory consulting, training, and auditing services to help clients comply with environmental and safety regulations.
Leadership Team and Corporate Structure:
Stericycle is led by Chief Executive Officer Cindy Miller, who took over in 2019. The company has a decentralized organizational structure with regional and business unit presidents reporting to the CEO.
Top Products and Market Share:
Top Products and Offerings:
- Medical Waste Management: Stericycle is the largest provider of medical waste management services in the US, with a market share of around 40%.
- Sharps Disposal: The company is a leading provider of sharps disposal containers and services, with a market share of around 30%.
- Document Destruction: Stericycle is a major player in the document destruction industry, with a market share of around 20%.
Market Share Analysis:
Stericycle is a market leader in several key segments of the environmental and regulated waste management industry. However, the company faces competition from regional players and other large competitors such as Veolia and Waste Management.
Product Performance and Market Reception:
Stericycle's products are generally well-received by customers. The company has a strong track record of innovation and customer service. However, the company has faced some challenges in recent years, including regulatory scrutiny and pricing pressure.
Total Addressable Market:
The global market for environmental and regulated waste management is estimated to be worth over $400 billion. The US market is the largest segment, with a value of over $150 billion.
Financial Performance:
Recent Financial Statements Analysis:
Stericycle's recent financial performance has been mixed. Revenue has been relatively flat in recent years, while earnings have declined. The company's profit margins have also come under pressure.
Year-over-Year Comparison:
Stericycle's revenue and earnings have declined year-over-year in recent quarters. The company's profit margins have also shrunk.
Cash Flow and Balance Sheet Health:
Stericycle has a strong cash flow position and a healthy balance sheet. However, the company has significant debt.
Dividends and Shareholder Returns:
Dividend History:
Stericycle has a history of paying dividends. The company's current dividend yield is around 1.5%.
Shareholder Returns:
Stericycle's stock has underperformed the market in recent years. The company's total shareholder return over the past 5 years is negative.
Growth Trajectory:
Historical Growth Analysis:
Stericycle's historical growth has been driven by acquisitions. The company's organic growth has been relatively slow in recent years.
Future Growth Projections:
Stericycle's future growth is expected to be driven by organic growth and acquisitions. The company is targeting a revenue growth rate of 3-5% in the coming years.
Recent Product Launches and Strategic Initiatives:
Stericycle has launched several new products and services in recent years, including a new line of sharps disposal containers and a new document destruction service. The company has also made several acquisitions, including the acquisition of Shred-it in 2015.
Market Dynamics:
Industry Overview:
The environmental and regulated waste management industry is a mature industry with low growth rates. The industry is also fragmented, with many regional players.
Stericycle's Positioning:
Stericycle is a leading player in the industry with a strong market share and a diversified business model. The company is well-positioned to benefit from the growing demand for environmental services.
Adaptability to Market Changes:
Stericycle has a track record of adapting to market changes. The company has invested in new technologies and services to meet the changing needs of its customers.
Competitors:
Key Competitors:
- Veolia (VIE)
- Waste Management (WM)
- Republic Services (RSG)
- Clean Harbors (CLH)
Market Share Comparison:
Stericycle is the market leader in several key segments of the industry. However, the company faces stiff competition from its rivals.
Competitive Advantages and Disadvantages:
Stericycle's competitive advantages include its large size, its strong brand recognition, and its diversified business model. However, the company's disadvantages include its high debt levels and its exposure to regulatory risk.
Potential Challenges and Opportunities:
Key Challenges:
- Supply Chain Issues: Stericycle is facing supply chain issues due to the COVID-19 pandemic and other factors.
- Technological Changes: The company is facing technological changes in the waste management industry, such as the adoption of new disposal methods.
- Competitive Pressures: Stericycle is facing increased competition from its rivals.
Potential Opportunities:
- New Markets: Stericycle is expanding into new markets, such as China and India.
- Product Innovations: The company is developing new products and services, such as new waste disposal technologies.
- Strategic Partnerships: Steri
About NVIDIA Corporation
Exchange NASDAQ | Headquaters Bannockburn, IL, United States | ||
IPO Launch date 1996-08-23 | President, CEO & Director Ms. Cindy J. Miller | ||
Sector Industrials | Industry Waste Management | Full time employees 13095 | Website https://www.stericycle.com |
Full time employees 13095 | Website https://www.stericycle.com |
Stericycle, Inc., together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions. It also provides secure information destruction services, including document, hard drive, destruction services under the Shred-it brand. The company serves healthcare businesses, including hospitals, health systems, non-affiliate hospitals, national and corporate healthcare, physician offices, surgery centers, veterinary and dental clinics, nursing and long-term care facilities, clinics and urgent care, dialysis centers, pharmacy, lab, research centers, home health organizations, etc.; and airports and seaports, education institutions, funeral homes and crematories, government and military, banks and professional services, and other businesses. Stericycle, Inc. was incorporated in 1989 and is headquartered in Bannockburn, Illinois. As of November 4, 2024, Stericycle, Inc. operates as a subsidiary of Waste Management, Inc.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.